New diabetes clinical trial: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Published on: December 11, 2024 at 11:00PM
Conditions: Type 2 Diabetes Mellitus
Interventions: Drug: ORMD-0801 8 mg; Other: Placebo capsule; Drug: ORMD-0801 16 mg
Sponsors: Oramed, Ltd.; InClin, Inc.
Not yet recruiting
https://ift.tt/eIPFaR4